tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR

Compare Pharming Group (PHAR) vs. Competitors

Compare
176 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$18.44
$1.30B
1,280.56
93.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Trevi Therapeutics
$13.47
$1.34B
-28.23
177.25%
9 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$12.12
$1.18B
-7.00
20.72%
11 Buy
1 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$317.25
$8.69B
-24.59
351.60%
13 Buy
0 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$10.63
$1.05B
-13.12
-12.73%
4 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.98
$718.43M
-2.70
38.68%
4 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
18.44
8.89
93.09%
TRVI
Trevi Therapeutics
10.48
6.92
194.38%
ORIC
Oric Pharmaceuticals
12.12
2.12
21.20%
PRAX
Praxis Precision Medicines
317.25
238.99
305.38%
SPRY
ARS Pharmaceuticals
10.63
-2.85
-21.14%
PRME
Prime Medicine, Inc.
3.98
1.07
36.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts